Man Group
IART icon

Man Group’s Integra LifeSciences IART Stock Holding History

Man Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,135
Closed -$257K – 2079
2024
Q3 		$257K Sell
14,135
-9,435
-40% -$219K ﹤0.01% 1800
2024
Q2 		$687K Sell
23,570
-17,038
-42% -$505K ﹤0.01% 1592
2024
Q1 		$1.44M Buy
40,608
+31,539
+348% +$1.26M ﹤0.01% 1423
2023
Q4 		$395K Buy
+9,069
New +$357K ﹤0.01% 1748
2023
Q3 		– Sell
-37,356
Closed -$1.57M – 792
2023
Q2 		$1.54M Buy
+37,356
New +$1.8M ﹤0.01% 1273
2023
Q1 		– Sell
-26,676
Closed -$1.5M – 1023
2022
Q4 		$1.5M Sell
26,676
-2,176
-8% -$111K 0.01% 1202
2022
Q3 		$1.22M Buy
+28,852
New +$1.48M 0.01% 1222
2022
Q2 		– Sell
-51,821
Closed -$3.11M – 1036
2022
Q1 		$3.33M Sell
51,821
-19,849
-28% -$1.31M 0.01% 1050
2021
Q4 		$4.8M Sell
71,670
-19,175
-21% -$1.3M 0.02% 888
2021
Q3 		$6.22M Sell
90,845
-4,297
-5% -$304K 0.02% 754
2021
Q2 		$6.49M Buy
95,142
+18,651
+24% +$1.32M 0.02% 773
2021
Q1 		$5.28M Sell
76,491
-47,893
-39% -$3.24M 0.02% 660
2020
Q4 		$8.07M Buy
124,384
+56,751
+84% +$3.05M 0.04% 536
2020
Q3 		$3.19M Buy
+67,633
New +$3.22M 0.01% 1023
2020
Q2 		– Sell
-77,475
Closed -$3.46M – 1721
2020
Q1 		$3.46M Buy
77,475
+44,675
+136% +$2.34M 0.02% 647
2019
Q4 		$1.91M Sell
32,800
-10,447
-24% -$622K 0.01% 1339
2019
Q3 		$2.6M Buy
43,247
+39,223
+975% +$2.34M 0.01% 1157
2019
Q2 		$225K Sell
4,024
-68,263
-94% -$3.52M ﹤0.01% 1787
2019
Q1 		$4.03M Buy
72,287
+30,154
+72% +$1.54M 0.02% 1029
2018
Q4 		$1.9M Sell
42,133
-17,503
-29% -$960K 0.01% 1237
2018
Q3 		$3.93M Sell
59,636
-738
-1% -$45.9K 0.01% 1123
2018
Q2 		$3.89M Buy
60,374
+35,092
+139% +$2.17M 0.02% 1067
2018
Q1 		$1.4M Buy
+25,282
New +$1.33M 0.01% 1401

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Man Group's IART Position: Q4 2024 in Review

Man Group sold out of Integra LifeSciences (IART) in Q4 2024, closing a stake of 14,135 shares — an estimated $257K sold.

Man Group first reported a position in IART in Q1 2018 and held it in 23 quarters. The position peaked at $8.07M in Q4 2020. 223 funds tracked by Wall St. Rank hold IART as of Q4 2024.

  • Man Group reported no remaining Integra LifeSciences position as of Q4 2024 after selling out during the quarter.
  • Man Group sold 14,135 Integra LifeSciences shares in Q4 2024, an estimated $257K.
  • Man Group first reported a position in Integra LifeSciences in Q1 2018 and held it in 23 quarters.
  • Man Group's Integra LifeSciences position peaked at $8.07M in Q4 2020.
  • 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2024.

Based on Man Group's 13F filing for Q4 2024, filed 14 Feb 2025.